Skip to main content
Elsevier
View Cart

Myoclonous

  • 1st Edition, Volume 11 - August 1, 2026
  • Latest edition
  • Editors: Peter Jenner, Marina AJ de Koning-Tijssen, Cristian Falup-Pecurariu
  • Language: English

Myoclonous, Volume 11 in the International Review of Movement Disorders series, highlights new advances in the field, with this new volume presenting interesting chapters on t… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Explore resources

Description

Myoclonous, Volume 11 in the International Review of Movement Disorders series, highlights new advances in the field, with this new volume presenting interesting chapters on topics such as Classification & Scales & Treatment, Electrophysiology, Diagnostic approach including differential diagnosis, Clinical Myclonus Syndromes, Cortical myclonus tremor, Spectrum of Progressive myclonus ataxia - Progressive myclonus epilepsy, Myclonus-dystonia, Functional myclonus, Genetic myclonus including genetic Metabolic disorders causing myclonus, Acquired myclonus (Toxic- and drug-induced, hypoxic-ischemic, Metabolic (non-genetic) and Inflammatory myclonus), Autoimmune and paraneoplastic myclonus, Neurodegenerative disorders and myclonus, and much more.

Key features

  • Provides the latest information on Myoclonous research
  • Offers outstanding and original reviews on a range of Myoclonous research topics
  • Serves as an indispensable reference for researchers and students alike

Readership

Undergraduates, graduates, academics, and researchers

Table of contents

1. Classification & Scales & Treatment
John Caviness and Ashley Pena

2. Electrophysiology
Anna Latorre and Shabbir Hussain Merchant

3. Diagnostic approach including differential diagnosis
Rodi Zutt and Martijne Oudkerk
Clinical Myclonus Syndromes

4. Cortical myclonus tremor
Antonietta Coppola, Fleur van Rootselaar and Christel Depienne

5. Spectrum of Progressive myclonus ataxia - Progressive myclonus epilepsy
Sterre van der Veen and Canafoglia Laura

6. Myclonus-dystonia
Kathryn Peall and Emmanuel Roze

7. Functional myclonus
Mark Edwards and Roberto Erro
Etiology

8. Genetic myclonus including genetic Metabolic disorders causing myclonus
Tom J. de Koning and Lisette Koens

9. Acquired myclonus (Toxic- and drug-induced, hypoxic-ischemic, Metabolic (non-genetic) and Inflammatory myclonus)
Sanjay Pandey, Jamir Pitton Rissardo and Kartika Gulati

10. Autoimmune and paraneoplastic myclonus
Jeroen Kerstens, Maarten J. Titulaer, Bart PC van de Warrenburg and Juna M. de Vries

11. Neurodegenerative disorders and myclonus
Robert Chen, Antonio Suppa, Talyta Cortez Grippe and Marco Falletti

Product details

  • Edition: 1
  • Latest edition
  • Volume: 11
  • Published: August 1, 2026
  • Language: English

About the editors

PJ

Peter Jenner

Professor Peter Jenner is a specialist in preclinical aspects of neurodegenerative diseases, notably Parkinson’s disease. He has spent the major part of his career at King’s College London where he was Head of Pharmacology for 14 years before returning to his research roots and subsequently becoming Emeritus Professor of Pharmacology. Peter has expertise in drug metabolism and pharmacokinetics but neuropharmacology based on functional models of neurodegenerative diseases has formed the major focus of his work. Peter holds a BPharm, PhD and DSc degree from the University of London. He has published well over 1000 articles with more than 700 peer reviewed papers. He is a Fellow of the Royal Pharmaceutical Society, the British Pharmacological Society, the Royal Society of Medicine and of King’s College London. Peter was recently honoured with a Doctor Honoris Causa degree from Carol Davila University of Medicine and Pharmacy, Bucharest and made an Honorary Fellow of The British Pharmacological Society for his contribution to research in to movement disorders. Peter has worked closely with the pharmaceutical industry for many years and acts as an adviser and consultant to both major pharma and biotech companies. He has a wide knowledge of the drug discovery and drug development process and has been involved from molecule synthesis through to drug registration for use in man. Peter was the Founder, Director and Chief Scientific Officer of Proximagen, a biotech focussed on the treatment and cure of neurodegenerative diseases that was listed on AIMs and subsequently purchased by a US based healthcare company. He is a regular speaker at international meetings and also takes time to speak at Parkinson’s disease patient-carer groups across the UK.
Affiliations and expertise
Emeritus Professor of Pharmacology, Institute of Pharmaceutical Sciences, King’s College London, London, UK

CF

Cristian Falup-Pecurariu

Cristian Falup-Pecurariu is Head of the Department of Neurology, County Clinic Hospital from Brasov, and is Full Professor of Neurology at the Transilvania University from Brasov, Romania. He received his medical degree from the University of Medicine and Pharmacy “Iuliu Hatieganu” from Cluj-Napoca. He hold a 1 year fellowship of the European Neurological Society in movement disorders at Hospital Clinic, University of Barcelona, Spain.

During his career Cristian Falup-Pecurariu was President of the European Association of Young Neurologists and Trainees (EAYNT), EAYNT Liasion Officer with World Federation of Neurological Society, co-representative of Europe on the International Working Group for Young Neurologists and Trainees (World Federation of Neurology). He was also Secretary of the EFNS/MDS-ES Panel on Movement Disorders, member of the Educational Committee of MDS-ES, member of the MDS Leadership Task Force and European Academy of Neurology Scientific Panel Movement Disorders, member of the Teaching Course sub-Committee of the European Academy of Neurology (EAN), currently being member of the Program Committee of EAN. Falup-Pecurariu is former Chair of the Education Committee of the MDS-ES, former member of the Executive Committee of MDS-ES, former member of the International Executive Committee of MDS. He is the initiator and Course Director of the Movement Disorders Teaching Course held in Brasov (12th editions). His research focuses on motor and non-motor aspects of Parkinson’s diseases.

Affiliations and expertise
Chair, Department of Neurology, County Emergency Clinic Hospital, Associate Professor of Neurology, Faculty of Medicine, Transilvania University, Brasov, Romania